Chemistry for biology: IGF-1 and [Gly7D-Ala]IGF-1 have been prepared by a total chemical synthesis and their folding and receptor-binding properties compared (see scheme). This approach facilitates the introduction of nonstandard amino acids whose biosynthetic incorporation is difficult or not feasible and thus promises to lead to a new generation of structure–activity studies of potential interest in the treatment of cancer and diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Sohma et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: